{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:24:27Z","timestamp":1790393067899,"version":"4.1.0"},"reference-count":19,"publisher":"Society of Nuclear Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2024,9,30]]},"DOI":"10.2967\/jnumed.124.268386","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T12:26:39Z","timestamp":1730291199000},"page":"jnumed.124.268386","source":"Crossref","is-referenced-by-count":10,"title":["Feasibility, Tolerability, and Preliminary Clinical Response of Fractionated Radiopharmaceutical Therapy with\n                    <sup>213<\/sup>\n                    Bi-FAPI-46: Pilot Experience in Patients with End-Stage, Progressive Metastatic Tumors"],"prefix":"10.2967","author":[{"given":"Andreas","family":"Helisch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Kratochwil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Kleist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jose","family":"Rosales Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Dendl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Rathke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"von Goetze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Schreckenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"J\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Mier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Giesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Haberkorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"R\u00f6hrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"key":"2024103009251528000_jnumed.124.268386v1.1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.210443"},{"key":"2024103009251528000_jnumed.124.268386v1.2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.210435"},{"key":"2024103009251528000_jnumed.124.268386v1.3","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.266046"},{"key":"2024103009251528000_jnumed.124.268386v1.4","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.220749"},{"key":"2024103009251528000_jnumed.124.268386v1.5","doi-asserted-by":"crossref","first-page":"854658","DOI":"10.3389\/fonc.2022.854658","article-title":"FAPI-PET\/CT in cancer imaging: a potential novel molecule of the century","volume":"12","author":"Huang","year":"2022","journal-title":"Front Oncol."},{"key":"2024103009251528000_jnumed.124.268386v1.6","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.261925"},{"key":"2024103009251528000_jnumed.124.268386v1.7","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.233122"},{"key":"2024103009251528000_jnumed.124.268386v1.8","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00259-021-05554-2","article-title":"Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer model","volume":"49","author":"Liu","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2024103009251528000_jnumed.124.268386v1.9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264338"},{"key":"2024103009251528000_jnumed.124.268386v1.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262468"},{"key":"2024103009251528000_jnumed.124.268386v1.11","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1158\/1078-0432.CCR-22-1432","article-title":"Safety and efficacy of 90Y-FAPI-46 radioligand therapy in patients with advanced sarcoma and other cancer entities","volume":"28","author":"Fendler","year":"2022","journal-title":"Clin Cancer Res."},{"key":"2024103009251528000_jnumed.124.268386v1.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.266411"},{"key":"2024103009251528000_jnumed.124.268386v1.13","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.224469"},{"key":"2024103009251528000_jnumed.124.268386v1.14","doi-asserted-by":"publisher","DOI":"10.2174\/1874471011205030221"},{"key":"2024103009251528000_jnumed.124.268386v1.15","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.189894"},{"key":"2024103009251528000_jnumed.124.268386v1.16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00259-022-05989-1","article-title":"Prognostic value of fibroblast activation protein expressing tumor volume calculated from [68Ga]Ga-FAPI PET\/CT in patients with esophageal squamous cell carcinoma","volume":"50","author":"Zhao","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2024103009251528000_jnumed.124.268386v1.17","first-page":"65","article-title":"Novel fibroblast activation protein inhibitor-based targeted theranostics for radioiodine-refractory differentiated thyroid cancer patients: a pilot study","volume":"32","author":"Ballal","year":"2022","journal-title":"Thyroid."},{"key":"2024103009251528000_jnumed.124.268386v1.18","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.259192"},{"key":"2024103009251528000_jnumed.124.268386v1.19","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41586-024-07461-6","article-title":"Covalent targeted radioligands potentiate radionuclide therapy","volume":"630","author":"Cui","year":"2024","journal-title":"Nature."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.124.268386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T12:26:41Z","timestamp":1730291201000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.124.268386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":19,"alternative-id":["10.2967\/jnumed.124.268386"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.124.268386","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,30]]}}}